Trials / Completed
CompletedNCT01048398
Remifentanil Versus Paracetamol for Pain Treatment External Cephalic Versions.
Remifentanil Versus Placebo for Pain Treatment External Cephalic Versions. Randomized, Controlled and Masked
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Basque Health Service · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
BACKGROUND: Between 3-4% of pregnancies carried to term, the fetuses are in breech presentation. The external version is a maneuver gynecological used to turn a breech in cephalic presentation. For treatment of pain suggests the use of μ agonist remifentanil for fast action and elimination. OBJECTIVE: To compare the effectiveness of remifentanil for pain management in external version. PATIENTS: Pregnant for 36 weeks or more with breech presentation who met the inclusion criteria and sign the consent. Participants will be randomized into two groups before the procedure. Group intervention: paracetamol and remifentanil Control group: paracetamol and placebo DETERMINATIONS: VAS pain level, percentage of success of the maneuver and adverse events. Statistical Analysis: Comparison of pain recorded by VAS in both groups and comparison of adverse events
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remifentanil | intervention: intravenous paracetamol 1g and remifentanil 1mg/100ml in 100ml of 0.9% saline. |
| DRUG | paracetamol | Control group: intravenous paracetamol 1g |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2010-01-13
- Last updated
- 2011-04-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01048398. Inclusion in this directory is not an endorsement.